Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

Abstract

Background The presence of emphysema is relatively common in patients with fibrotic interstitial lung disease. This has been designated combined pulmonary fibrosis and emphysema (CPFE). The lack of consensus over definitions and diagnostic criteria has limited CPFE research. Goals The objectives of this task force were to review the terminology, definition, characteristics, pathophysiology, and research priorities of CPFE and to explore whether CPFE is a syndrome. Methods This research statement was developed by a committee including 19 pulmonologists, 5 radiologists, 3 pathologists, 2 methodologists, and 2 patient representatives. The final document was supported by a focused systematic review that identified and summarized all recent publications related to CPFE. Results This task force identified that patients with CPFE are predominantly male, with a history of smoking, severe dyspnea, relatively preserved airflow rates and lung volumes on spirometry, severely impaired Dl CO, exertional hypoxemia, frequent pulmonary hypertension, and a dismal prognosis. The committee proposes to identify CPFE as a syndrome, given the clustering of pulmonary fibrosis and emphysema, shared pathogenetic pathways, unique considerations related to disease progression, increased risk of complications (pulmonary hypertension, lung cancer, and/or mortality), and implications for clinical trial design. There are varying features of interstitial lung disease and emphysema in CPFE. The committee offers a research definition and classification criteria and proposes that studies on CPFE include a comprehensive description of radiologic and, when available, pathological patterns, including some recently described patterns such as smoking-related interstitial fibrosis. Conclusions This statement delineates the syndrome of CPFE and highlights research priorities.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 319

1. 1.

   Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26:586-93.

   Not in our library10.1183/09031936.05.00021005

2. 2.

   Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest. 2009;136:1-2.

   Not in our library10.1378/chest.09-0538

3. 3.

   Wong AW, Liang J, Cottin V, Ryerson CJ. Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review. Ann Am Thorac Soc. 2020;17:1333-6.

   Not in our library10.1513/annalsats.202002-122rl

4. 4.

   Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008;53:707-14.

   Not in our library10.1111/j.1365-2559.2008.03183.x

5. 5.

   Katzenstein AL. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol. 2013;66:882-7.

   Not in our library10.1136/jclinpath-2012-201338

6. 6.

   Scadding JG. Health and disease: what can medicine do for philosophy? J Med Ethics. 1988;14:118-24.

   Not in our library10.1136/jme.14.3.118

7. 7.

   Mallory TB, Castleman B, Parris EE. Case records of the Massachusetts general hospital. Case 34191. New Engl J Med. 1948;238:667-71.

   Not in our library

8. 8.

   Robbins LL. Idiopathic pulmonary fibrosis: roentgenologic findings. Radiology. 1948;51:459-67.

   Not in our library10.1148/51.4.459

9. 9.

   Tourniaire A, Tartulier M, Blum J, Deyrieux F. [Early detection of pulmonary circulatory sound in pure fibrosis and in fibrosis complicated by emphysema]. Presse Med. 1966;74:2139-44.

   Not in our library

10. 10.

    Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smoker’s. N Engl J Med. 1974;291:755-8.

    Not in our library10.1056/nejm197410102911503

11. 11.

    Westcott JL, Cole SR. Traction bronchiectasis in end-stage pulmonary fibrosis. Radiology. 1986;161:665-9.

    Not in our library10.1148/radiology.161.3.3786716

12. 12.

    Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990;84:365-9.

    Not in our library10.1016/s0954-6111(08)80070-4

13. 13.

    Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;144:504-6.

    Not in our library10.1164/ajrccm/144.3_pt_1.504

14. 14.

    Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration. 1993;60:354-8.

    Not in our library10.1159/000196235

15. 15.

    Strickland NH, Hughes JM, Hart DA, Myers MJ, Lavender JP. Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: a combined CT and scintigraphic study. AJR. 1993;161:719-25.

    Not in our library10.2214/ajr.161.4.8372745

16. 16.

    Doherty MJ, Pearson MG, O’Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52:998-1002.

    Not in our library10.1136/thx.52.11.998

17. 17.

    Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med. 1997;155:1367-75.

    Not in our library10.1164/ajrccm.155.4.9105081

18. 18.

    Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999;154:1763-75.

    Not in our library10.1016/s0002-9440(10)65432-6

19. 19.

    Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167:962-9.

    Not in our library10.1164/rccm.2111053

20. 20.

    Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med. 2005;171:1363-70.

    Not in our library10.1164/rccm.200410-1349oc

21. 21.

    Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am J Respir Crit Care Med. 2005;172:1605.

    Not in our library10.1164/ajrccm.172.12.1605a

22. 22.

    Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol. 2006;19:1474-9.

    Not in our library10.1038/modpathol.3800671

23. 23.

    Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 2010;41:316-25.

    Not in our library10.1016/j.humpath.2009.09.003

24. 24.

    Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144:234-40.

    Not in our library10.1378/chest.12-2403

25. 25.

    Tzouvelekis A, Zacharis G, Oikonomou A, et al. Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med. 2013;13:31.

    Not in our library10.1186/1471-2466-13-31

26. 26.

    Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respiratory Medicine. 2009;103:1209-15.

    Not in our library10.1016/j.rmed.2009.02.001

27. 27.

    Alsumrain M, De Giacomi F, Nasim F, et al. Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival. Respir Med. 2019;146:106-12.

    Not in our library10.1016/j.rmed.2018.12.003

28. 28.

    Antoniou KM, Walsh SL, Hansell DM, et al. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology. 2013;18:1191-6.

    Not in our library10.1111/resp.12154

29. 29.

    Cottin V, Hansell DM, Sverzellati N, et al. Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017;196:1162-71.

    Not in our library10.1164/rccm.201612-2492oc

30. 30.

    Jacob J, Bartholmai BJ, Rajagopalan S, et al. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 2018;23:593-9.

    Not in our library10.1111/resp.13231

31. 31.

    Kurashima K, Takayanagi N, Tsuchiya N, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology. 2010;15:843-8.

    Not in our library10.1111/j.1440-1843.2010.01778.x

32. 32.

    Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136:10-5.

    Not in our library10.1378/chest.08-2306

33. 33.

    Tasaka S, Mizoguchi K, Funatsu Y, et al. Cytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema. Respirology. 2012.

    Not in our library10.1111/j.1440-1843.2012.02182.x

34. 34.

    Sangani R, Ghio A, Culp S, Patel Z, Sharma S. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort. Int J Chron Obstruct Pulmon Dis. 2021;16:1873-85.

    Not in our library10.2147/copd.s307192

35. 35.

    Sato S, Tanino Y, Misa K, et al. Identification of Clinical Phenotypes in Idiopathic Interstitial Pneumonia with Pulmonary Emphysema. Intern Med. 2016;55:1529-35.

    Not in our library10.2169/internalmedicine.55.6009

36. 36.

    Choi SH, Lee HY, Lee KS, et al. The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). PLoS One. 2014;9:e107476.

    Not in our library10.1371/journal.pone.0107476

37. 37.

    Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung. 2010;188:365-73.

    Not in our library10.1007/s00408-010-9251-6

38. 38.

    Zhang M, Yoshizawa A, Kawakami S, et al. The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema. Cancer Med. 2016;5:2721-30.

    Not in our library10.1002/cam4.858

39. 39.

    Gao L, Xie S, Liu H, et al. Lung cancer in patients with combined pulmonary fibrosis and emphysema revisited with the 2015 World Health Organization classification of lung tumors. Clin Respir J. 2018;12:652-8.

    Not in our library10.1111/crj.12575

40. 40.

    Sato S, Koike T, Hashimoto T, et al. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema. Annals of thoracic and cardiovascular surgery: official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia. 2016;22:216-23.

    Not in our library10.5761/atcs.oa.15-00315

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.